These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12728911)

  • 1. Environmental lead exposure and chronic renal disease.
    Lopes AA; Port FK
    N Engl J Med; 2003 May; 348(18):1810-2; author reply 1810-2. PubMed ID: 12728911
    [No Abstract]   [Full Text] [Related]  

  • 2. Environmental lead exposure and chronic renal disease.
    Elinder CG; Alvestrand A
    N Engl J Med; 2003 May; 348(18):1810-2; author reply 1810-2. PubMed ID: 12728912
    [No Abstract]   [Full Text] [Related]  

  • 3. Environmental lead exposure and chronic renal disease.
    Owda AK; Alam MG; Shah SV
    N Engl J Med; 2003 May; 348(18):1810-2; author reply 1810-2. PubMed ID: 12724490
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased body lead burden--cause or consequence of chronic renal insufficiency?
    Marsden PA
    N Engl J Med; 2003 Jan; 348(4):345-7. PubMed ID: 12540649
    [No Abstract]   [Full Text] [Related]  

  • 5. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does lead cause renal damage? Surprising results published in a respected journal].
    Elinder CG
    Lakartidningen; 2003 May; 100(19):1736. PubMed ID: 12800302
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
    Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing end-stage renal disease.
    J Occup Med; 1991 May; 33(5):584. PubMed ID: 1908008
    [No Abstract]   [Full Text] [Related]  

  • 10. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial.
    Lin JL; Ho HH; Yu CC
    Ann Intern Med; 1999 Jan; 130(1):7-13. PubMed ID: 9890856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes.
    Lin JL; Lin-Tan DT; Yu CC; Li YJ; Huang YY; Li KL
    Kidney Int; 2006 Jun; 69(11):2049-56. PubMed ID: 16641918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible hypothyroidism with EDTA chelation therapy in a patient with elevated lead burden and chronic renal insufficiency.
    Lin JL; Shih FC
    Nephrol Dial Transplant; 1997 Feb; 12(2):364-5. PubMed ID: 9132667
    [No Abstract]   [Full Text] [Related]  

  • 13. Environmental lead exposure and progressive renal insufficiency.
    Lin JL; Tan DT; Hsu KH; Yu CC
    Arch Intern Med; 2001 Jan; 161(2):264-71. PubMed ID: 11176742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lead nephropathy.
    Emmerson BT
    Kidney Int; 1973 Jul; 4(1):1-5. PubMed ID: 4353288
    [No Abstract]   [Full Text] [Related]  

  • 15. Chelation therapy for childhood lead poisoning. The changing scene in the 1990s.
    Mortensen ME; Walson PD
    Clin Pediatr (Phila); 1993 May; 32(5):284-91. PubMed ID: 8391959
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney disease in blacks in North America--an overview.
    Hosten AO
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):5-8. PubMed ID: 3564137
    [No Abstract]   [Full Text] [Related]  

  • 17. The need for vigilance: the persistence of lead poisoning in children.
    Florin TA; Brent RL; Weitzman M
    Pediatrics; 2005 Jun; 115(6):1767-8. PubMed ID: 15930242
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving behavior of lead-exposed children: micronutrient supplementation, chelation, or prevention.
    Chen A; Rogan WJ
    J Pediatr; 2005 Nov; 147(5):570-1. PubMed ID: 16291342
    [No Abstract]   [Full Text] [Related]  

  • 19. Lead intoxication in an anuric patient: management by intraperitoneal EDTA.
    Roger SD; Crimmins D; Yiannikas C; Harris DC
    Aust N Z J Med; 1990 Dec; 20(6):814-7. PubMed ID: 2127176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.